Michela Rimondini
Papers
1
Total Citations
3
H-Index
1
About
Michela Rimondini is a leading researcher in neurorehabilitation, with a primary focus on multiple sclerosis (MS) and gait disability. Her work centers on evaluating and advancing robot-assisted gait training (RAGT) as a therapeutic intervention for individuals with severe motor impairments. Rimondini’s major contribution lies in designing rigorous clinical trials that compare traditional versus progressive RAGT protocols, aiming to establish evidence-based rehabilitation strategies for people with MS. Her 2024 study protocol for the PROGR-EX trial, which has already garnered 3 citations, exemplifies her commitment to addressing the critical challenge of gait disorders—the most frequent and debilitating symptom in MS. By investigating whether progressive RAGT offers superior outcomes to conventional approaches, she is shaping the future of neurorehabilitation. Rimondini’s work has significant impact, as it directly informs clinical practice for patients with severe gait disability, a population often underserved by standard therapies. Her research is notable for its methodological rigor and potential to improve mobility and quality of life, making her a key figure in the intersection of robotics and neurological rehabilitation.
Research Focus
Key Achievements
Top Papers
- 1